EMS agencies receive recognition to improve quality of care for STEMI and Acute Coronary Syndrome patients

Translate to Spanish or other 102 languages!

Hidalgo County EMS and Med-Care EMS received the Bronze Plus award through the Mission: Lifeline EMS Recognition Program.

Mega Doctor News

- Advertisement -

Hidalgo County EMS and Med-Care EMS received the Bronze Plus award through the Mission: Lifeline EMS Recognition Program to improve quality of care for STEMI and Acute Coronary Syndrome patients. Lifeline falls under the American Heart Association, where EMS provider organizations are recognized for the improvement of patient care.

“Through our Texas Healthy Communities Grant, these agencies were awarded and are also the first in the Rio Grande Valley to be a part of this program where the whole purpose of our EMS 911 contractors and EMS programs is to save lives, and to encourage, that if a person is having a heart attack or a stroke, they are treated at advanced levels to get a higher incidences of recovery.”

Mission: Lifeline EMS Recognition, a program designed to showcase Emergency Medical Service organizations across the nation, focuses on saving lives of patients suffering from the most severe form of heart attack, as ST-elevated myocardial infarction, or STEMI, where the coronary artery is completely and suddenly blocked.

- Advertisement -

“We use evidence-based metrics to measure and improve the system’s performance, and outcomes in the community we serve,” said Med-Care EMS Director of Operations Mack Gilbert.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -